Results 1 to 10 of about 3,132,866 (232)

Impact of prior dengue infection on severity and outcomes: meta-analysis of placebo-controlled trials

Revista Panamericana de Salud Pública
Objective. This study evaluated the association between serologically confirmed prior dengue infection and the subsequent risk of virologically confirmed dengue, severe dengue, dengue hospitalization, dengue-related death and all-cause mortality. Methods.
Alejandro Macchia, Silvana Figar, Cristián Biscayart, Fernán González Bernaldo de Quirós   +3 more
doaj   +1 more source

Pro- and anti-inflammatory cytokines signatures at different severity of dengue infection

Journal of Family Medicine and Primary Care
Context: Dengue disease severity and progression are determined by the host immune response, with both pro- and anti-inflammatory cytokines are key mediators.
Himani Prajapati, Vivek Kumar, Garima Mittal, Yogesh Saxena   +3 more
doaj   +1 more source

Severe COVID-19 multisystem inflammatory syndrome versus severe dengue in children from Indonesia: a cross-sectional study

International Journal of Emergency Medicine
Introduction Severe multisystem inflammatory syndrome in children (MIS-C) and severe dengue are challenging to identify during the COVID-19 pandemic in dengue-endemic areas.
Anggraini Alam, Fina Meilyana Andriyani, Stanza Uga Peryoga   +2 more
doaj   +1 more source

Urinary Neutrophil Mediators as Predictive Biomarkers for Severe Dengue in Adults. [PDF]

Open Forum Infect Dis
Teo A, Chia PY, Ho S, Yeo TW.
europepmc   +1 more source

Role of Hemoperfusion With HA330 in the Management of Severe Dengue Shock Syndrome. [PDF]

J Trop Med
Virojtriratana T, Nan KN, Samransamruajkit R.   +2 more
europepmc   +1 more source

Evaluation of immune-endothelial activation markers for the differentiation of severe dengue. [PDF]

J Transl Med
Khor YS, Sam SS, Tong KL, AbuBakar S, Misbah S, Azmel A, Kamal Faizul PNAB, Shunmugarajoo A, Mageswaren E, Soh YH, Ab Rahman AK, Wong PF.   +11 more
europepmc   +1 more source

Perturbed pediatric circulating metabolome in mild and severe dengue disease. [PDF]

J Virol
Soma PS, Gullberg RC, Graham B, Islam MN, Kuan G, Balmaseda A, Blair CD, Beaty BJ, Belisle JT, Harris E, Perera R.   +10 more
europepmc   +1 more source

Early and late biomarkers as predictors of severe dengue: a comprehensive umbrella review protocol. [PDF]

BMJ Open
Gunasekera KM, Seneviwickrama M, Ranasinghe S, Gamage K, Gonapaladeniya M.   +4 more
europepmc   +1 more source

A Case of Severe Dengue With Hemophagocytic Lymphohistiocytosis (HLH) Successfully Managed With Tocilizumab and Dexamethasone. [PDF]

Cureus
Wedasingha S, Wijerathna I, Herath P, Amarasena A, Senanayake H.   +4 more
europepmc   +1 more source

Dengue 2025 global surge: urgent call to bolster hospital preparedness for severe dengue. [PDF]

Ann Med Surg (Lond)
Mehmood MS, Hajj F.
europepmc   +1 more source